Hiring Freeze, Layoffs?

Discussion in 'Boehringer Ingelheim' started by anonymous, Jan 15, 2019 at 2:03 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Forceranking and training on other products to add to your bag. The good old days are coming back.
     

  2. anonymous

    anonymous Guest

    HSBS have been calling on specialist since the beginning, so what about that is new in your scenario?
     
  3. anonymous

    anonymous Guest


    They only call on specialists within their system. I wonder if they would call on all specialists. I don't think they could cover the ground if they did.
     
  4. anonymous

    anonymous Guest

    HSBS is the backbone of a district. They know what’s going on before anyone and know which way to steer the ship.
    Laugh all you want- they are the advisors to FPM and up.
    Now they are invited to the table to force rank divisions and help identify the good apples. With careful coordination with KAM / FPM and Senior leaders- the new Go 2 Market or Go Home will be established. Best time to sell and put some numbers on the board team!
     
  5. anonymous

    anonymous Guest

    HSBM here. This post is BS. Some jank stirring the pot.
     
  6. anonymous

    anonymous Guest

    HSBS REPS are going to be involved with decisions that have HR implications? Riiiiiight...
     
  7. anonymous

    anonymous Guest

    nice! My HSBS can’t even decide who to call on. Maybe they can decide to wipe themselves. I hope they aren’t involved with any more complex decisions
     
  8. anonymous

    anonymous Guest

    HSBS is The BS of BI and the industry...
     
  9. anonymous

    anonymous Guest

    Soon they will not need any of us. BI will have remote reps! Which, by the way we should promote to the docs. Okay doc please dont make time to talk with me but do talk to the remote rep because they can say more than me.
     
  10. anonymous

    anonymous Guest

    Seems like some territories are getting moved around in Q2. Think it might be hospital territories around the country. Not sure if that would just be HSBS or what it means. There are so many rumors flying around right now. This needs to get worked out very soon. No one is operating at full potential when there's this much crap floating around. I have no clue what is going to happen, but I do believe that Q2 something is going down here.
     
  11. Dip master p

    Dip master p Guest

    Just do your job yip pity yap dip pat de doo slappity yang
     
  12. anonymous

    anonymous Guest

    By now it is obvious, something is likely to happen at least once per year. "Go to Market" is a process. If you are scared then you better start looking for a new job. If you can handle the uncertainty then keep your head in the game and you MIGHT be rewarded. Whining is pathetic.
     
  13. anonymous

    anonymous Guest

    As far as i can tell you're the only one whining. The others seem to be trying to get an idea of what is happening so they as best prepared as possible.
     
  14. anonymous

    anonymous Guest

    Well then you’re not telling far enough. H2 2019 is where things will happen. Nothing in Q2.
     
  15. anonymous

    anonymous Guest

    Who really cares if there is a hiring freeze? Call us the hell of primary care. Reality is we have crap products for today. Pradaxa dying and less than what 2% share, every other company but BI recognizes respiratory is dying space in 2019 - many generics coming, and this leaves the crown jewel Jardiance - me too in space of many. Let’s go have fun and sell! Wait we have an emerging pipeline - oops missed on that too.
     
  16. anonymous

    anonymous Guest


    Primary care will be completely dead in the next couple of years. There’s absolutely nothing in the pipeline for PC.
    Resp reps have about 2 years and then it’s over.
     
  17. anonymous

    anonymous Guest

    Respiratory crapped the bed with indecisive leadership and lack of foresight. Look at the market it’s easy to see other companies have better vision and resources. It’s obvious when senior leaders leave.
    Rest in Mist respiratory
     
  18. anonymous

    anonymous Guest

    This seems pretty accurate. COPD is way too overcrowded, everyone begging for a smaller piece of the pie. Nothing to truly differentiate one product from another. We stupidly never got a triple which would have differentiated us. Spiriva off Patent, Pradaxa off patent. Just make the changes, people can focus on the future.
     
  19. anonymous

    anonymous Guest

    New territories, teams, and TBMs’ team assignments are being finalized this week. Skype cc invites (with little to no details) will come out just when no one is expecting it. Major announcements will be made just prior to Thanksgiving. Good luck to all.
     
  20. anonymous

    anonymous Guest